scholarly article | Q13442814 |
P356 | DOI | 10.1159/000351864 |
P8608 | Fatcat ID | release_3ea7dra375gwtg4vhm5r3gwlge |
P698 | PubMed publication ID | 24107412 |
P50 | author | Ana Sofia Costa | Q45722281 |
Jörg B. Schulz | Q52088891 | ||
Kathrin Reetz | Q40125730 | ||
P2093 | author name string | Arno Reich | |
Bruno Fimm | |||
Simon Thomas Ketteler | |||
P2860 | cites work | Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease | Q48258228 |
Montreal Cognitive Assessment: influence of sociodemographic and health variables | Q48745434 | ||
Deterioration of visual-perceptual organization ability in Alzheimer's disease | Q48900093 | ||
Official position of the american academy of clinical neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts | Q50691804 | ||
Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke. | Q50761901 | ||
Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA): confirmatory factor analysis. | Q51860172 | ||
A total score for the CERAD neuropsychological battery. | Q51928190 | ||
Revising the definition of Alzheimer's disease: a new lexicon. | Q53313597 | ||
Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting. | Q53330739 | ||
Revised research diagnostic criteria for Alzheimer's disease. | Q53394473 | ||
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. | Q55053125 | ||
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study | Q28728080 | ||
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment | Q29615678 | ||
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates | Q33591798 | ||
Methods for assessing responsiveness: a critical review and recommendations | Q33919427 | ||
Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database | Q33924622 | ||
Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample | Q34019643 | ||
The MoCA: well-suited screen for cognitive impairment in Parkinson disease. | Q34024621 | ||
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study | Q35004787 | ||
Visual assessment of posterior atrophy development of a MRI rating scale | Q35552599 | ||
A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia | Q38399595 | ||
Measuring cognition in a geriatric outpatient clinic: Rasch analysis of the Montreal Cognitive Assessment | Q43683733 | ||
Changes on brief cognitive instruments over time in Parkinson's disease | Q43843579 | ||
P433 | issue | 1-2 | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 95-103 | |
P577 | publication date | 2013-10-08 | |
P1433 | published in | Dementia and Geriatric Cognitive Disorders | Q15749436 |
P1476 | title | Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease | |
P478 | volume | 37 |
Q55072113 | Change in Cognition and Other Non-Motor Symptoms With Obstructive Sleep Apnea Treatment in Parkinson Disease. |
Q38636474 | Cognitive Improvement and Brain Changes after Real-Time Functional MRI Neurofeedback Training in Healthy Elderly and Prodromal Alzheimer's Disease |
Q36751172 | Comparison of Alternate and Original Items on the Montreal Cognitive Assessment. |
Q45297926 | Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases |
Q36688859 | Outcome measures for Parkinson's disease dementia: a systematic review |
Q57809539 | Postoperative cognitive dysfunction after cochlear implantation |
Q35674661 | Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease. |
Q36298580 | Sensitivity to change and prediction of global change for the Alzheimer's Questionnaire |
Q47393517 | Trajectory and variability characterization of the Montreal cognitive assessment in older adults |
Q57039646 | White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients |
Q36809236 | Working Memory Network Changes in ALS: An fMRI Study |
Q50745557 | [Trail walking test for assessment of motor cognitive interference in older adults. Development and evaluation of the psychometric properties of the procedure]. |
Search more.